1-[[(4-Nitrophenyl)methyl]sulfonyl]-pyrrolidine

340041-91-0

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterp♥rise that is market-oriented and realizes industrial development through R&​;D innovation and technology transformation.

key word:

technology Pharmaceutical

Category:

Consulting
Related

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to build a large health ind'ustry finance platform company integrating pharmaceutical, intelligent medical, bio pharma♦ceutical R&D, industrial production and sales.

The chemical reactions involved in the existing products in®clude Foucault reaction, nitration reaction, sulfona&tion reaction, hydrogenation reaction, fluorination® reaction, chlorination reaction, bromination reaction, diazotization re★action, format reaction, etc.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor developed by Merck. In Octσober 2006, Sitagliptin phosphate Januvia was approved× by FDA as the first DPP4 inhibitor for the treatment of type ⅱ diabetes♠ mellitus. The characteristics of this drug are that it can stimulate insulin secretion while r≈educing hunger without causing weight gain. Hypoglycemia and e←dema will not occur, and it is suitable for diabet∏ic patients with poor blood glucose control and frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-orie≈nted and realizes industrial development through R&D innovation and∏ technology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most imp→ortant products for the treatment of arthritis. It is well tolera₽ted and has a low incidence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major lΩeukotriene receptor antagonists. In clinical application, it has good therapeutic eff±ect on atopic asthma and other types of bronchial asthma, and the' market prospect is huge. In the major category of asthma drugs, leukotr‌iene receptor antagonists have the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pαharmaceutical enterprise that is market-oriented and realiz$es industrial development through R&D innovation and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is t≥he second drug approved by FDA for Alzheimer's disease in the Unite↓d States. Its treatment reaches the target dose and has low toxic and side effects. It has b≥een widely recognized by our medical community, and good tolerance is its b₽iggest advantage. In October 1999, Donepezil was launched in✔ China under the trade name "Aricept", which is the main chemical drug a∑gainst Alzheimer's disease. At present, CFDA has approved a number÷ of domestic enterprises to produce donepezil preparation<s, the main dosage forms are tablets, capsules, dispersive tablets, oral disintegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliquis, Bristol-Myers Squibb/Pfiz∑er), a direct oral factor Xa inhibitor, was approved for use in→ the 27 EU member states. The world's first drug approved to prevent venous thromboembolism (VT✘E) in adult patients undergoing elective hip or knee replace ment. From June 2019 to June 2020, the annual sales of apixaban product↓s overseas reached about $15.4 billion, with a year-on-year growth of♦ nearly 32%, and the API consumption reached about 23,960 kg, with a year-on-‍year growth of about 28%. Compared with its main competitor, Rivaroxabaεn, the drug's annual overseas sales are about $4.5 bi$llion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical ‌enterprise that is market-oriented and realizes industrial de×velopment through R&D innovation and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactured by Genzyme. On December 29, ★2004, it was approved by FDA for the treatment of refractory or relapsed acute >lymphoblastic leukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-orien$ted and realizes industrial development through R&D innovation and→ technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If you need other services, ♣E-mail: 2880705932@qq.com
Submit